No abstract

No abstract

BackgroundRadiation-induced osteosarcomas are a recognized complication of radiation therapy. Owing to the fact that it is rare, publications on radiation-induced osteosarcoma of the skull base are limited to a small series and some case reports.Case presentationWe describe a rare case of a patient with a skull base radiation-induced osteosarcoma treated 11 years before with ionizing radiation for an undifferentiated carcinoma of the nasopharynx. The patient was treated with chemotherapy alone, but he died after the third cycle.ConclusionsRadiation-induced osteosarcoma of the skull base after treatment of nasopharyngeal carcinoma is a very rare but very aggressive complication with a poor prognosis. Chemotherapy gives bad results, and regular follow-up of treated patients should be considered.

BackgroundPrimary ductal adenocarcinomas of the lacrimal gland are very rare. This neoplasm shares some histological and immunohistochemical similarities with salivary duct carcinoma.Case presentationHere, we present a case of a 55-year-old Moroccan man with lacrimal gland adenocarcinoma. He underwent orbital exenteration with lymph nodes dissection and ipsilateral parotidectomy. After surgery, he was lost to follow-up and died 13 months later.ConclusionsLacrimal gland tumors are rare but highly aggressive salivary gland tumors. Complete excision with adjuvant radiotherapy is recommended.

Purpose: to study the clinical, radiological, therapeutic and progressive aspects of brain radionecrosis after treatment for nasopharyngel carcinoma. Patients and methods: four patients ( two men and two women) of mean age 53.5 years were treated for UCNT( undifferentiated carcinoma of the nasopharynx), between 2009and 2014, and developed cerebral radionecrosis. All patients were treated with radical radiotherapy. The mean dose was 70 Gy. Dose per fraction was 2 Gy, one fraction daily. All patients received chemotherapy. Result: patients presented non specific neurological signs, and one case was discovered fortuitously. The mean latent periode was 46 months, brain radionecrosis was authetificated by brain imaging. The localisation was temporal in two patients and bulbomedullar in two patients. After a mean follow-up period of 14 months, clinical outcomes were favorable in one case, stabilisation in two cases and one patient died. Conclusion: brain radionecrosis is a rare iatrogenic complication for patients irradiated for UCNT. Imaging techniques play a major role in the diagnosis. Corticotherapy is the main treatment.